Abeona Therapeutics Inc vs SkyWest Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while SkyWest Inc trades at $108.98 (market cap $4.19B). The key difference: SkyWest Inc is far larger — about 9.9× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | SKYW | |
|---|---|---|
Market Cap | $421.19M | $4.19B |
Sector | Health | Technology |
52-Week High | $7.45 | $123.72 |
52-Week Low | $4.17 | $78.40 |
Enterprise Value | $276.10M | $5.97B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →